THE EVOLUTION OF IMMUNOSUPPRESSION WITH FK506 IN PEDIATRIC LIVING-RELATED LIVER TRANSPLANTATION1-Reference-Cited by-同舟云学术

THE EVOLUTION OF IMMUNOSUPPRESSION WITH FK506 IN PEDIATRIC LIVING-RELATED LIVER TRANSPLANTATION1

Published:1996-01 Issue:2 Volume:61 Page:247-252
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Inomata Yukihiro,Tanaka Koichi,Egawa Hiroto,Uemoto Shinji,Ozaki Nobuhiro,Okajima Hideaki,Satomura Kazunari,Kiuchi Tetsuya,Yamaoka Yoshio,Hashida Tohru

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference27 articles.

1. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.

2. FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.

3. FK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATION

4. A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of Pediatric Liver Transplantation in Japan: A Report from the Registry of the Japanese Liver Transplantation Society;Transplantation;2021-11-22

2. The impact of rituximab prophylaxis on hepatocellular carcinoma recurrence after living donor liver transplantation;Hepatoma Research;2021

3. Donor‐dominant one‐way matching of human leukocyte antigen‐A/B/DR alleles predicts graft‐versus‐host disease following living donor liver transplantation;Hepatology Research;2020-10-20

4. Older Donor Age Is a Risk Factor for Negative Outcomes After Adult Living Donor Liver Transplantation Using Small‐for‐Size Grafts;Liver Transplantation;2019-08-14

5. Impact of Graft Quality and Fluid Overload on Postoperative Massive Ascites After Living Donor Liver Transplantation;Transplantation Proceedings;2019-07